Home / AVCRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AVCRF make money? Does AVCRF have pricing power? What's the Earnings Whisper? Will AVCRF profit more as the business scales? What is AVCRF's management track record? Is AVCRF's current price justified?

Avricore Health Inc.

$0 -$0.03 (-97.50%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.04

Year Range

$0$0.08

Market Cap

81.03K

AVG Volume

36.53K

Trailing/Forward PE

-3.41/-

PEG ratio

0.15

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

AVCRF Revenue (CAD) by quarter
Period	Revenue (CAD)
26 Q2	75.12K
26 Q1	44.43K
25 Q4	33.42K
25 Q3	37.73K
25 Q2	28.69K
25 Q1	434.06K
24 Q4	1.42M
24 Q3	1.2M
24 Q2	1.05M
24 Q1	1.12M

Net Income (CAD)

AVCRF Net Income (CAD) by quarter
Period	Net Income (CAD)
26 Q2	-266.57K
26 Q1	-205.42K
25 Q4	-942.32K
25 Q3	-379.82K
25 Q2	-459.01K
25 Q1	-77.36K
24 Q4	-712.52K
24 Q3	-179.01K
24 Q2	54.02K
24 Q1	168.54K

Operating Income (CAD)

AVCRF Operating Income (CAD) by quarter
Period	Operating Income (CAD)
26 Q2	-230.76K
26 Q1	-240.66K
25 Q4	-449.61K
25 Q3	-379.08K
25 Q2	-471.56K
25 Q1	-73.81K
24 Q4	82.22K
24 Q3	-173.36K
24 Q2	71.8K
24 Q1	164.74K

EBITDA (CAD)

AVCRF EBITDA (CAD) by quarter
Period	EBITDA (CAD)
26 Q2	-221.96K
26 Q1	-224.61K
25 Q4	-445.74K
25 Q3	-331.1K
25 Q2	-426.18K
25 Q1	-31.38K
24 Q4	195.47K
24 Q3	-57.63K
24 Q2	167.03K
24 Q1	274.33K

Cash Flows (CAD)

AVCRF Cash Flows (CAD) by quarter
Period	Cash Flows (CAD)
26 Q2	-462.07K
26 Q1	-28.35K
25 Q4	-300.39K
25 Q3	-321.42K
25 Q2	-413.5K
25 Q1	137.07K
24 Q4	334.37K
24 Q3	172.46K
24 Q2	-29.43K
24 Q1	321.87K

EPS (CAD)

AVCRF EPS (CAD) by quarter
Period	EPS (CAD)
26 Q2	-0
26 Q1	-0
25 Q4	-0.01
25 Q3	-0
25 Q2	-0
25 Q1	-0
24 Q4	-0.01
24 Q3	-0
24 Q2	0
24 Q1	0

Expenses (CAD)

AVCRF Expenses (CAD) by quarter
Period	Expenses (CAD)
26 Q2	232.37K
26 Q1	217.08K
25 Q4	448.13K
25 Q3	284.54K
25 Q2	412.41K
25 Q1	481.69K
24 Q4	712.12K
24 Q3	610.84K
24 Q2	339.47K
24 Q1	393.71K

Cash & Debt (CAD)

AVCRF Cash & Debt (CAD) by quarter
Period	Cash & Debt (CAD)
26 Q2	922.95K
26 Q1	210.84K
25 Q4	237.72K
25 Q3	542.52K
25 Q2	865.19K
25 Q1	1.28M
24 Q4	1.14M
24 Q3	790.51K
24 Q2	565.61K
24 Q1	594.04K

Debt ratios

AVCRF Debt ratios by quarter
Period	Debt ratios
26 Q2	0.75
26 Q1	0.15
25 Q4	0.19
25 Q3	0.91
25 Q2	2.71
25 Q1	-4.68
24 Q4	-1.97
24 Q3	-1.38
24 Q2	-1.21
24 Q1	-5.55

Margins

AVCRF Margins by quarter
Period	Margins
26 Q2	1.9%
26 Q1	-28.96%
25 Q4	-16.87%
25 Q3	-143.14%
25 Q2	-167.63%
25 Q1	79.78%
24 Q4	41.51%
24 Q3	36.38%
24 Q2	35.47%
24 Q1	43.05%

Return on Capital

AVCRF Return on Capital by quarter
Period	Return on Capital
26 Q2	-24.01%
26 Q1	-104.96%
25 Q4	-242.09%
25 Q3	-29.33%
25 Q2	-28.32%
25 Q1	-3.96%
24 Q4	-36.21%
24 Q3	-7.19%
24 Q2	2.37%
24 Q1	7.59%

Shares Outstanding

AVCRF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	104.87M
26 Q1	101.29M
25 Q4	101.29M
25 Q3	101.29M
25 Q2	101.29M
25 Q1	101.29M
24 Q4	100.09M
24 Q3	99.87M
24 Q2	99.87M
24 Q1	99.74M

Book Value Per Share (CAD)

AVCRF Book Value Per Share (CAD) by quarter
Period	Book Value Per Share (CAD)
26 Q2	0.01
26 Q1	0
25 Q4	0
25 Q3	0.01
25 Q2	0.02
25 Q1	0.02
24 Q4	0.02
24 Q3	0.02
24 Q2	0.02
24 Q1	0.02

Total Assets (CAD)

AVCRF Total Assets (CAD) by quarter
Period	Total Assets (CAD)
26 Q2	1.24M
26 Q1	585.88K
25 Q4	562.66K
25 Q3	1.33M
25 Q2	1.67M
25 Q1	2.14M
24 Q4	2.3M
24 Q3	3.02M
24 Q2	2.62M
24 Q1	2.8M

Employee Count

AVCRF Employee Count by quarter
Period	Employee Count
2024	1
2023	1
2022	1
2018	2
2017	9
2016	8
2013	350
2012	350
2011	3
2010	3

PE Ratio

AVCRF PE Ratio by quarter
Period	PE Ratio
Jun 25	35.5
Jun 25	56.14
May 25	59.85
May 25	42.87
May 25	47.54
May 25	37.64
May 25	66.88
Apr 25	41.57
Apr 25	41.52
Apr 25	42.82
Apr 25	47.99
Mar 25	64.47
Mar 25	42.21
Mar 25	40.94
Mar 25	22.31
Feb 25	46.62
Feb 25	57.54
Feb 25	57.4
Feb 25	57.82
Jan 25	61.39
Jan 25	60.61
Jan 25	66.15
Jan 25	53.05
Jan 25	57.9

Free Cash Flow Yield

AVCRF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-946.49%
Sep 26	-949.04%
Aug 26	-30.22%
Aug 26	-30.52%
Aug 26	-30.28%
Aug 26	-30.14%
Jul 26	-29.98%
Jul 26	-21.85%
Jul 26	-15.51%
Jul 26	-11.19%
Jul 26	-17.98%
Jun 26	-20.72%
Jun 26	-13.73%
Jun 26	-13.86%
Jun 26	-13.92%
May 26	-20.55%
May 26	-19.78%
May 26	-14.8%
May 26	-4.77%
May 26	-4.42%
Apr 26	-3.16%
Apr 26	-3.17%
Apr 26	-3.18%
Apr 26	-4.04%
Mar 26	-3.18%
Mar 26	-3.39%
Mar 26	-3.57%
Mar 26	-3.13%
Feb 26	-3.49%
Feb 26	-3.19%
Feb 26	-3.61%
Feb 26	-3.66%
Jan 26	-4.27%
Jan 26	-2.73%
Jan 26	-2.87%
Jan 26	-5.94%
Jan 26	-5.91%
Dec 25	6.19%
Dec 25	3.9%
Dec 25	4.75%
Dec 25	5.84%
Nov 25	5.28%
Nov 25	5.23%
Nov 25	4.39%
Nov 25	4.09%
Oct 25	4.09%
Oct 25	4.93%
Oct 25	2.98%
Oct 25	3.35%
Oct 25	4%
Sep 25	3.56%
Sep 25	3.63%
Sep 25	8.92%
Sep 25	8.07%
Aug 25	7.99%
Aug 25	10.4%
Aug 25	9.44%
Aug 25	7.53%
Aug 25	6.46%
Jul 25	6.12%
Jul 25	8.78%
Jul 25	9.29%
Jul 25	13.7%
Jun 25	16.22%
Jun 25	13.51%
Jun 25	9.61%
Jun 25	6.08%
May 25	5.7%
May 25	7.96%
May 25	7.18%
May 25	9.07%
May 25	5.1%
Apr 25	8.21%
Apr 25	8.22%
Apr 25	7.97%
Apr 25	7.11%
Mar 25	5.29%
Mar 25	8.08%
Mar 25	8.34%
Mar 25	15.3%
Feb 25	7.32%
Feb 25	5.93%
Feb 25	5.95%
Feb 25	5.9%
Jan 25	5.56%
Jan 25	5.63%
Jan 25	5.16%
Jan 25	6.43%
Jan 25	5.89%
Dec 24	1.62%
Dec 24	1.63%
Dec 24	1.32%
Dec 24	1.1%
Nov 24	1.79%
Nov 24	1.55%
Nov 24	1.37%
Nov 24	0.61%
Nov 24	0.63%
Oct 24	0.61%
Oct 24	0.53%

Price to Sales

AVCRF Price to Sales by quarter
Period	Price to Sales
Sep 26	0.78
Sep 26	0.78
Aug 26	24.4
Aug 26	24.16
Aug 26	24.35
Aug 26	24.46
Jul 26	24.59
Jul 26	33.74
Jul 26	47.54
Jul 26	15.03
Jul 26	9.35
Jun 26	8.12
Jun 26	12.25
Jun 26	12.14
Jun 26	12.08
May 26	8.19
May 26	8.5
May 26	11.37
May 26	2.88
May 26	3.1
Apr 26	4.34
Apr 26	4.33
Apr 26	4.31
Apr 26	3.4
Mar 26	4.31
Mar 26	4.05
Mar 26	3.84
Mar 26	4.37
Feb 26	3.92
Feb 26	4.3
Feb 26	3.8
Feb 26	3.75
Jan 26	3.21
Jan 26	5.02
Jan 26	4.78
Jan 26	2.31
Jan 26	2.32
Dec 25	1.21
Dec 25	1.92
Dec 25	1.57
Dec 25	1.28
Nov 25	1.42
Nov 25	1.43
Nov 25	1.7
Nov 25	1.83
Oct 25	1.83
Oct 25	1.52
Oct 25	2.51
Oct 25	2.24
Oct 25	1.87
Sep 25	2.1
Sep 25	2.06
Sep 25	1.68
Sep 25	1.86
Aug 25	1.88
Aug 25	1.44
Aug 25	1.59
Aug 25	1.99
Aug 25	2.32
Jul 25	2.45
Jul 25	1.71
Jul 25	1.62
Jul 25	1.1
Jun 25	1.03
Jun 25	1.24
Jun 25	0.78
Jun 25	1.23
May 25	1.31
May 25	0.94
May 25	1.04
May 25	0.82
May 25	1.46
Apr 25	0.91
Apr 25	0.91
Apr 25	0.94
Apr 25	1.05
Mar 25	1.41
Mar 25	0.92
Mar 25	0.89
Mar 25	0.49
Feb 25	1.02
Feb 25	1.26
Feb 25	1.25
Feb 25	1.26
Jan 25	1.34
Jan 25	1.32
Jan 25	1.45
Jan 25	1.16
Jan 25	1.27
Dec 24	1.33
Dec 24	1.33
Dec 24	1.63
Dec 24	1.95
Nov 24	1.21
Nov 24	1.39
Nov 24	1.57
Nov 24	3.56
Nov 24	3.42
Oct 24	3.56
Oct 24	4.06

EV/EBITDA

AVCRF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 25	20.51
Sep 25	23.15
Aug 25	23.43
Aug 25	16.92
Aug 25	19.11
Aug 25	25.17
Aug 25	30.09
Jul 25	32.03
Jul 25	20.9
Jul 25	19.52
Jul 25	11.72
Jun 25	6.54
Jun 25	8.24
Jun 25	5.02
Jun 25	8.74
May 25	9.41
May 25	6.35
May 25	7.19
May 25	5.4
May 25	10.67
Apr 25	6.11
Apr 25	6.1
Apr 25	6.34
Apr 25	7.27
Mar 25	10.24
Mar 25	6.23
Mar 25	6
Mar 25	2.64
Feb 25	7.02
Feb 25	8.99
Feb 25	8.96
Feb 25	9.04
Jan 25	9.68
Jan 25	9.54
Jan 25	10.54
Jan 25	8.18
Jan 25	9.06
Dec 24	11.53
Dec 24	11.5
Dec 24	14.41
Dec 24	17.5
Nov 24	10.36
Nov 24	12.08
Nov 24	13.83
Nov 24	32.87
Nov 24	31.55
Oct 24	32.84
Oct 24	37.69
Oct 24	37.58
Oct 24	46.6
Sep 24	191.86
Sep 24	182.29
Sep 24	182.53
Sep 24	218.74
Aug 24	264.4
Aug 24	269.46
Aug 24	284.86
Aug 24	211.74
Aug 24	285.57
Jul 24	273.25
Jul 24	234.13
Jul 24	159.12
Jul 24	147.51

Price/Operating Cashflow

AVCRF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Dec 25	9.33
Dec 25	14.78
Dec 25	12.14
Dec 25	9.88
Nov 25	10.93
Nov 25	11.03
Nov 25	13.14
Nov 25	14.11
Oct 25	14.1
Oct 25	11.71
Oct 25	19.34
Oct 25	17.24
Oct 25	14.43
Sep 25	16.23
Sep 25	15.88
Sep 25	8.42
Sep 25	9.3
Aug 25	9.4
Aug 25	7.22
Aug 25	7.95
Aug 25	9.98
Aug 25	11.63
Jul 25	12.27
Jul 25	8.55
Jul 25	8.09
Jul 25	5.48
Jun 25	4.91
Jun 25	5.89
Jun 25	4.04
Jun 25	6.39
May 25	6.81
May 25	4.88
May 25	5.41
May 25	4.28
May 25	7.61
Apr 25	4.73
Apr 25	4.73
Apr 25	4.88
Apr 25	5.46
Mar 25	7.34
Mar 25	4.81
Mar 25	4.66
Mar 25	2.54
Feb 25	5.31
Feb 25	6.55
Feb 25	6.53
Feb 25	6.58
Jan 25	6.99
Jan 25	6.9
Jan 25	7.53
Jan 25	6.04
Jan 25	6.59
Dec 24	7.01
Dec 24	6.99
Dec 24	8.6
Dec 24	10.29
Nov 24	6.37
Nov 24	7.32
Nov 24	8.28
Nov 24	18.75
Nov 24	18.03
Oct 24	18.74
Oct 24	21.41
Oct 24	21.35
Oct 24	26.31
Sep 24	21.72
Sep 24	20.66
Sep 24	20.69
Sep 24	24.67
Aug 24	29.69
Aug 24	30.25
Aug 24	31.94
Aug 24	23.9
Aug 24	32.02
Jul 24	30.67
Jul 24	26.37
Jul 24	18.11
Jul 24	16.84
Jun 24	26.5
Jun 24	26.92
Jun 24	45.7
May 24	39.08
May 24	43.22
Apr 24	24.21
Apr 24	24.4
Apr 24	24.04
Apr 24	34.77
Mar 24	39.05
Feb 24	39.63
Feb 24	34.68
Feb 24	34.61
Feb 24	34.55
Feb 24	39.3
Jan 24	39.25
Jan 24	39.18
Jan 24	34.41
Jan 24	48.77
Dec 23	37.4

Price to Book

AVCRF Price to Book by quarter
Period	Price to Book
Sep 26	0.57
Sep 26	0.57
Aug 26	17.99
Aug 26	17.81
Aug 26	17.95
Aug 26	18.03
Jul 26	18.13
Jul 26	24.87
Jul 26	35.05
Jul 26	20.62
Jul 26	12.83
Jun 26	11.14
Jun 26	16.8
Jun 26	16.65
Jun 26	16.57
May 26	11.23
May 26	11.67
May 26	15.59
May 26	4.27
May 26	4.61
Apr 26	6.44
Apr 26	6.42
Apr 26	6.4
Apr 26	5.04
Mar 26	6.4
Mar 26	6.01
Mar 26	5.7
Mar 26	6.49
Feb 26	5.82
Feb 26	6.37
Feb 26	5.63
Feb 26	5.56
Jan 26	4.76
Jan 26	7.46
Jan 26	7.1
Jan 26	3.43
Jan 26	3.44
Dec 25	2.3
Dec 25	3.64
Dec 25	2.99
Dec 25	2.43
Nov 25	2.69
Nov 25	2.72
Nov 25	3.24
Nov 25	3.48
Oct 25	3.47
Oct 25	2.89
Oct 25	4.76
Oct 25	4.25
Oct 25	3.56
Sep 25	4
Sep 25	3.91
Sep 25	3.53
Sep 25	3.9
Aug 25	3.94
Aug 25	3.03
Aug 25	3.33
Aug 25	4.18
Aug 25	4.87
Jul 25	5.14
Jul 25	3.58
Jul 25	3.39
Jul 25	2.3
Jun 25	2.5
Jun 25	3.01
Jun 25	1.47
Jun 25	2.33
May 25	2.48
May 25	1.78
May 25	1.97
May 25	1.56
May 25	2.77
Apr 25	1.72
Apr 25	1.72
Apr 25	1.77
Apr 25	1.99
Mar 25	2.67
Mar 25	1.75
Mar 25	1.7
Mar 25	0.92
Feb 25	1.93
Feb 25	2.38
Feb 25	2.38
Feb 25	2.4
Jan 25	2.54
Jan 25	2.51
Jan 25	2.74
Jan 25	2.2
Jan 25	2.4
Dec 24	2.62
Dec 24	2.61
Dec 24	3.21
Dec 24	3.84
Nov 24	2.38
Nov 24	2.73
Nov 24	3.09
Nov 24	7
Nov 24	6.73
Oct 24	6.99
Oct 24	7.99

No video analysis for this stock yet. Request one from our team.

News: AVCRF

globenewswire.com · 1 Sep 2026

HealthTab™ Programme Expands Nationally Across England

VANCOUVER, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that NHS England has confirmed the national expansion of the Barts Health pharmacy cholesterol testing programme powered by Avricore's HealthTab™ platform.

globenewswire.com · 28 Aug 2026

Avricore Grants Options

VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company's board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.

globenewswire.com · 20 Aug 2026

HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott's point-of-care testing products through the HealthTab™ platform in the UK.

globenewswire.com · 17 Jun 2026

Avricore Health Closes $1.254 Million Financing

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces that, further to its news release dated May 20, 2026, the Company has closed its non-brokered private placement for gross proceeds of $1,254,000 by issuing 25,080,000 Units at $0.05 per Unit on June 16, 2026.